Management of benign prostatic hyperplasia (BPH)

被引：1
作者：
Jokisch J.-F. [1 ]
Herlemann A. [1 ]
Weinhold P. [1 ]
Magistro G. [1 ]
Stief C.G. [1 ]
Gratzke C. [1 ]
机构：
[1] Urologische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, München
来源：
MMW - Fortschritte der Medizin | 2017年 / 159卷 / 9期
关键词：
Benign prostatic syndrome (BPS); bladder outlet obstruction (BOO); lower urinary tract symptoms (LUTS); medical treatment / surgical treatment;
D O I：
10.1007/s15006-017-9046-2
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：58 / 64
页数：6
相关论文
共 50 条
  • [21] Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study
    Wang, Mao Qiang
    Wang, Yan
    Yan, Jie Yu
    Yuan, Kai
    Zhang, Guo Dong
    Duan, Feng
    Li, Kai
    WORLD JOURNAL OF UROLOGY, 2016, 34 (09) : 1275 - 1283
  • [22] Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance
    Jin, Renjie
    Forbes, Connor M.
    Miller, Nicole L.
    Lafin, John
    Strand, Douglas W.
    Case, Thomas
    Cates, Justin M.
    Liu, Qi
    Ramirez-Solano, Marisol
    Mohler, James L.
    Matusik, Robert J.
    PROSTATE, 2024, 84 (05) : 441 - 459
  • [23] Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study
    Mao Qiang Wang
    Yan Wang
    Jie Yu Yan
    Kai Yuan
    Guo Dong Zhang
    Feng Duan
    Kai Li
    World Journal of Urology, 2016, 34 : 1275 - 1283
  • [24] Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia
    Garg, Ankur
    Bansal, Shweta
    Saha, Sudipta
    Kumar, Ajay
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (01) : 215 - 220
  • [25] Alpha-1 Adrenergic Antagonists Induced Severe Rhinitis in Patients with Benign Prostatic Hyperplasia
    Shahar, Eduardo
    Nassar, Laila
    Kedem, Eynat
    Hassoun, Gammal
    CURRENT DRUG SAFETY, 2014, 9 (02) : 159 - 160
  • [26] A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)
    Novara, Giacomo
    Chapple, Christopher R.
    Montorsi, Francesco
    BJU INTERNATIONAL, 2014, 114 (03) : 427 - 433
  • [27] Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period
    Bilhim, Tiago
    Costa, Nuno Vasco
    Torres, Daniel
    Pinheiro, Luis Campos
    Spaepen, Erik
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (09) : 1324 - 1336
  • [28] Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period
    Tiago Bilhim
    Nuno Vasco Costa
    Daniel Torres
    Luís Campos Pinheiro
    Erik Spaepen
    CardioVascular and Interventional Radiology, 2022, 45 : 1324 - 1336
  • [29] Is Holmium Laser Enucleation of Prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study
    Mostafa, Mostafa M.
    Patil, Nilesh
    Khalil, Mahmoud
    Elgammal, Mohammed A.
    Mahdy, Ayman
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2022, 94 (02) : 174 - 179
  • [30] The use of PDE-5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
    Casey Lythgoe
    Kevin T. McVary
    Current Urology Reports, 2013, 14 : 585 - 594
12345